BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38589872)

  • 1. Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments.
    Fernández-Arjona MDM; Navarro JA; López-Gambero AJ; de Ceglia M; Rodríguez M; Rubio L; Rodríguez de Fonseca F; Barrios V; Chowen JA; Argente J; Rivera P; Suárez J
    Biol Sex Differ; 2024 Apr; 15(1):34. PubMed ID: 38589872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family.
    Babiker A; Al Noaim K; Al Swaid A; Alfadhel M; Deeb A; Martín-Rivada Á; Barrios V; Pérez-Jurado LA; Alfares A; Al Alwan I; Argente J
    Clin Genet; 2021 Nov; 100(5):601-606. PubMed ID: 34272725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant IGF-1 Induces Sex-Specific Changes in Bone Composition and Remodeling in Adult Mice with
    Rubio L; Vargas A; Rivera P; López-Gambero AJ; Tovar R; Christians JK; Martín-de-Las-Heras S; Rodríguez de Fonseca F; Chowen JA; Argente J; Suárez J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment.
    Mastrangelo A; Martos-Moreno GÁ; Rupérez FJ; Chowen JA; Barbas C; Argente J
    Growth Horm IGF Res; 2018; 42-43():28-31. PubMed ID: 30119035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-associated plasma protein-A2 (PAPP-A2): tissue expression and biological consequences of gene knockout in mice.
    Conover CA; Boldt HB; Bale LK; Clifton KB; Grell JA; Mader JR; Mason EJ; Powell DR
    Endocrinology; 2011 Jul; 152(7):2837-44. PubMed ID: 21586553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAPP-A2 expression by osteoblasts is required for normal postnatal growth in mice.
    Amiri N; Christians JK
    Growth Horm IGF Res; 2015 Dec; 25(6):274-80. PubMed ID: 26385171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation.
    Fujimoto M; Andrew M; Liao L; Zhang D; Yildirim G; Sluss P; Kalra B; Kumar A; Yakar S; Hwa V; Dauber A
    Endocrinology; 2019 Jun; 160(6):1363-1376. PubMed ID: 30977789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic disorders of GH action pathway.
    Domené HM; Fierro-Carrión G
    Growth Horm IGF Res; 2018 Feb; 38():19-23. PubMed ID: 29249625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy associated plasma protein A2 (PAPP-A2) affects bone size and shape and contributes to natural variation in postnatal growth in mice.
    Christians JK; de Zwaan DR; Fung SH
    PLoS One; 2013; 8(2):e56260. PubMed ID: 23457539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.
    Fujimoto M; Hwa V; Dauber A
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):1-8. PubMed ID: 29280739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects.
    Fujimoto M; Andrew M; Dauber A
    Mol Cell Endocrinol; 2020 Dec; 518():110967. PubMed ID: 32739295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of Pappa2 gene may indirectly affect mouse hip development through the IGF signaling pathway.
    Chen Y; Li L; Wang E; Zhang L; Zhao Q
    Endocrine; 2019 Aug; 65(2):440-450. PubMed ID: 31168749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF)-I and IGF-II contribute differentially to the phenotype of pregnancy associated plasma protein-A knock-out mice.
    Mason EJ; Grell JA; Wan J; Cohen P; Conover CA
    Growth Horm IGF Res; 2011 Oct; 21(5):243-7. PubMed ID: 21802327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pappa2 deletion alters IGFBPs but has little effect on glucose disposal or adiposity.
    Christians JK; Bath AK; Amiri N
    Growth Horm IGF Res; 2015 Oct; 25(5):232-9. PubMed ID: 26164771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pappa2 deletion has sex- and age-specific effects on bone in mice.
    Christians JK; Amiri N; Schipilow JD; Zhang SW; May-Rashke KI
    Growth Horm IGF Res; 2019 Feb; 44():6-10. PubMed ID: 30445407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency.
    Muñoz-Calvo MT; Barrios V; Pozo J; Chowen JA; Martos-Moreno GÁ; Hawkins F; Dauber A; Domené HM; Yakar S; Rosenfeld RG; Pérez-Jurado LA; Oxvig C; Frystyk J; Argente J
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3879-3883. PubMed ID: 27648969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAPP-A2 deficiency does not exacerbate the phenotype of a mouse model of intrauterine growth restriction.
    Christians JK; Lennie KI; Huicochea Munoz MF; Binning N
    Reprod Biol Endocrinol; 2018 Jun; 16(1):58. PubMed ID: 29895300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papp-a2 modulates development of cranial cartilage and angiogenesis in zebrafish embryos.
    Kjaer-Sorensen K; Engholm DH; Jepsen MR; Morch MG; Weyer K; Hefting LL; Skov LL; Laursen LS; Oxvig C
    J Cell Sci; 2014 Dec; 127(Pt 23):5027-37. PubMed ID: 25236600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood.
    Fujimoto M; Khoury JC; Khoury PR; Kalra B; Kumar A; Sluss P; Oxvig C; Hwa V; Dauber A
    Eur J Endocrinol; 2020 Mar; 182(3):363-374. PubMed ID: 31961798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.
    Dauber A; Muñoz-Calvo MT; Barrios V; Domené HM; Kloverpris S; Serra-Juhé C; Desikan V; Pozo J; Muzumdar R; Martos-Moreno GÁ; Hawkins F; Jasper HG; Conover CA; Frystyk J; Yakar S; Hwa V; Chowen JA; Oxvig C; Rosenfeld RG; Pérez-Jurado LA; Argente J
    EMBO Mol Med; 2016 Apr; 8(4):363-74. PubMed ID: 26902202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.